Critical Review of Guidelines for BPH Diagnosis and Treatment Strategy
Authors:
- Antonio GalfanoAGAntonio Galfano
- Walter ArtibaniWAWalter Artibani
- 1 April 2006
- journal article
- review article
- Published by Elsevier in European Urology Supplements
- Vol. 5 (4) , 418-429
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- A Double-Blind Placebo-Controlled Study Evaluating the Onset of Action of Doxazosin Gastrointestinal Therapeutic System in the Treatment of Benign Prostatic HyperplasiaEuropean Urology, 2005
- Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH)European Urology, 2005
- Validity of Digital Rectal Examination and Serum Prostate Specific Antigen in the Estimation of Prostate Volume in Community-Based Men Aged 50 to 78 Years: The Krimpen StudyEuropean Urology, 2004
- Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladderBJU International, 2004
- Efficacy and Safety of Long-Term Treatment with the Dual 5α-Reductase Inhibitor Dutasteride in Men with Symptomatic Benign Prostatic HyperplasiaEuropean Urology, 2004
- The Relation of Lower Urinary Tract Symptoms with Life-Style Factors and Objective Measures of Benign Prostatic Enlargement and Obstruction: An Italian SurveyEuropean Urology, 2004
- Optimising the Medical Management of Benign Prostatic HyperplasiaEuropean Urology, 2004
- Combination Treatment With an α-Blocker Plus an Anticholinergic for Bladder Outlet Obstruction: A Prospective, Randomized, Controlled StudyJournal of Urology, 2003
- Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE projectQuality and Safety in Health Care, 2003
- Phytotherapy for benign prostatic hyperplasiaPublic Health Nutrition, 2000